Enhanced expression of renal endothelin-converting enzyme-1 and endothelin-A-receptor mRNA in rats with interstitial fibrosis following ureter ligation

Journal of Cardiovascular Pharmacology

Volumn 36, Issue 5 SUPPL. 1, 2000, Pages

  Feldman, D L ^a   Mogelesky, T C ^a   Chou, M ^a   Jeng, A Y ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Endothelin A (ET(A)); Endothelin converting enzyme 1 (ECE 1); Interstitial injury fibrosis; Ureter ligation

Indexed keywords

COLLAGEN TYPE 3; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN CONVERTING ENZYME; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOLOGY; IMMUNOFLUORESCENCE; KIDNEY FIBROSIS; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; URETER LIGATION;

EID: 0033744178     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200036001-00094     Document Type: Article

References (20)

1. Tubulointerstitial changes as a major determinant in the progression of renal damage
2. Enalapril reduces collagen synthesis and expansion of the interstitium in the obstructed rat kidney
3. New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy
4. The pathophysiology of obstructive nephropathy: The role of vasoactive compounds in the hemodynamic and structural abnormalities of the obstructed kidney
5. Macrophages, monocytes chemoattractant peptide-1, and TGF-b1 in experimental hydronephrosis
6. Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis
7. Interstitial fibrosis in obstructive nephropathy
8. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction
9. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy
10. Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension
11. Endothelins in the normal and diseased kidney
12. Endothelin in the progressive renal disease of glomerulopathies
13. Regulation of mRNA expression for ECM by cultured rat mesangial cells
14. Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat
15. Renal tissue endothelin in long-term complete ureteric obstruction in the young rat
16. Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney
17. Endothelin-1 and endothelin B type receptor are induced in mesangial proliferative nephritis in the rat
18. Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli
19. Effect of a specific endothelin A receptor antagonist on murine lupus nephritis
20. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression